Urea Compounds and Their Use as FAAH Enzyme Inhibitors
申请人:BIAL-PORTELA & Cª, S.A.
公开号:US20160166560A1
公开(公告)日:2016-06-16
A compound having Formula I:
wherein: R1 is selected from hydrogen, halogen, hydroxyl and C
1-4
alkoxy; R2 is selected from hydrogen, halogen, hydroxyl and C
1-4
alkoxy; R3 is C
1-4
alkyl; R4 is aryl which is substituted with a group selected from OSO
2
NH
2
, NHCONH
2
, NHSO
2
NH
2
, NHSO
2
C
1-4
alkyl and CONH
2
; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that the compound is not N-(1-benzylpiperidin-4-yl)-N-methyl-4-(4-(sulfamoylamino)phenyl)-1H-imidazole-1-carboxamide or N-(1-benzylpiperidin-4-yl)-N-methyl-4-(3-(methyl sulfonamido)phenyl)-1H-imidazole-1-carboxamide. The compound may be used as an inhibitor of fatty acid amide hydrolase.
UREA COMPOUNDS AND THEIR USE AS FAAH ENZYME INHIBITORS
申请人:BIAL - Portela & Cª S.A.
公开号:EP3027610A1
公开(公告)日:2016-06-08
[EN] UREA COMPOUNDS AND THEIR USE AS FAAH ENZYME INHIBITORS<br/>[FR] COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH
申请人:BIAL PORTELA & Cª S A
公开号:WO2015016728A1
公开(公告)日:2015-02-05
A compound having Formula (I): wherein: R1 is selected from hydrogen, halogen, hydroxyl and C1-4 alkoxy; R2 is selected from hydrogen, halogen, hydroxyl and C1-4 alkoxy; R3 is C1-4 alkyl; R4 is aryl which is substituted with a group selected from OSO2NH2, NHCONH2, NHSO2NH2, NHSO2C1-4 alkyl and CONH2; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that the compound is not N-(1-benzylpiperidin-4-yl)-N-methyl-4-(4-(sulfamoylamino)phenyl)-1H-imidazole-1-carboxamide or N-(1-benzylpiperidin-4-yl)-N-methyl-4-(3-(methylsulfonamido)phenyl)-1H-imidazole-1-carboxamide. The compound may be used as an inhibitor of fatty acid amide hydrolase.